Novartis Unbranded Hypertension Ad Cited For Link To Diovan Promotion
Executive Summary
Novartis has had two conference calls with FDA's Division of Drug Marketing, Advertising & Communications to discuss the agency's concerns about unbranded ads connected with the company's direct-to-consumer Diovan (valsartan) campaign
You may also be interested in...
Ads Linking “Help-Seeking” and Full Product Spots Helps Consumers – Pfizer
Similarities between branded ads and disease awareness ads may benefit consumers and should not be prohibited by FDA, Pfizer says
Ads Linking “Help-Seeking” and Full Product Spots Helps Consumers – Pfizer
Similarities between branded ads and disease awareness ads may benefit consumers and should not be prohibited by FDA, Pfizer says
Novartis To Consider “Off Shoring” Some Corporate Functions To India
Novartis will consider "off shoring" certain corporate functions to India